Related Experiment Video
Updated: Oct 4, 2025

06:16
mirMachine: A One-Stop Shop for Plant miRNA Annotation
Published on: May 1, 2021
2.6K
Predicting miRNA targets for hepatocellular carcinoma with an integrated method
Yi-Hua Shi1, Tian-Fu Wen1, De-Shuang Xiao1
1Department of General Surgery, The First People's Hospital of Wenling, Wenling 317500, China.
Translational Cancer Research
|February 4, 2022
Summary
This study introduces an integrated method to identify microRNA (miRNA) targets for hepatocellular carcinoma (HCC). The approach successfully predicted 50 confident miRNA-mRNA interactions, offering potential diagnostic and therapeutic biomarkers.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- MicroRNAs (miRNAs) play crucial roles in cancer, acting as oncogenes or tumor suppressors.
- Aberrant miRNA regulation is observed in various cancers, including hepatocellular carcinoma (HCC).
- Identifying miRNA targets is essential for understanding cancer mechanisms and developing therapies.
Purpose of the Study:
- To develop and validate an integrated computational method for predicting microRNA (miRNA) targets in hepatocellular carcinoma (HCC).
- To identify high-confidence miRNA-messenger RNA (mRNA) interactions relevant to HCC.
- To explore the functional significance of predicted target genes through pathway analysis.
Main Methods:
- An integrated method combining correlation (Pearson's correlation coefficient), causal inference (IDA), and regression (Lasso) was developed using the Borda count algorithm.
- Predicted miRNA targets were validated against a confirmed database.
- Pathway enrichment analysis was performed on identified target genes.
Main Results:
- The integrated method proved effective for predicting miRNA targets.
- Fifty highly confident miRNA-mRNA interactions were identified, with 6 miRNAs predicted as targets at least 10 times.
- Enrichment analysis revealed 26 significant pathways among the top 1,000 miRNA-mRNA interactions, notably complement and coagulation cascades.
Conclusions:
- The findings provide valuable insights into HCC pathogenesis and potential diagnostic/therapeutic biomarkers.
- Further experimental validation is required to confirm the identified miRNA-mRNA interactions and their clinical utility.
- The study highlights the potential of integrated bioinformatics approaches in cancer research.

